Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
In 2024, comparing Itot and Vti costs helps identify the more economical choice for long-term retirement goals.
28,280 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Turning 65 is a milestone, but it also opens a maze of Medicare decisions. This article reveals a Medicare mistake co...
AI data centers are expanding fast, backed by major cloud players. This article dives into why hyperscalers plan spen...
Equities drift lower as oil prices jump, lifting energy shares and weighing on risk appetite. The S&P 500 retreats wh...
Choosing between broad healthcare stability and biotech growth can shape your portfolio. Learn how XLV and IBBQ diffe...
Two midstream ETFs compete on tax structure and cash-flow strategy. A closer look at AMLP and MLPX reveals how holdin...
As the three-year mark of the Ripple-SEC ruling arrives, XRP has moved from regulator target to institutional asset, ...
A landmark ruling reshapes trade policy and could alter stock market dynamics. This guide breaks down what happened, ...
Warren Buffett weighed social beliefs and offered practical ideas on how to shore up Social Security. This article br...
Prediction markets tied to the World Cup final surge to record volumes, with Spain favored over Argentina as betting ...
Antalpha's bold bet on tokenized gold XAUt has yielded more than $100 million in unrealized gains, with a recent tran...
Walmart’s John Furner rose from a garden center associate to CEO of Walmart U.S., guiding the retailer through a tech...